Alexandria Real Estate Equities (ARE) Stock Price, Quote & News

Company Profile

Alexandria Real Estate Equities, Inc., an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science and advanced technology innovation cluster locations, including Greater Boston, San Diego, the San Francisco Bay...

Industry: REIT - Office

Sector: Real Estate

Phone: 626 578 0777

Fax: 626 578 0896

Website: www.are.com

Address:

26 North Euclid Avenue, Pasadena, United States

StockFactz Sep. 23 at 7:10 PM

$ARE Down 8% a week before divy what a blessing

0 · Reply

StockFactz Sep. 23 at 7:07 PM

$ARE Wow okay filled, lets go +500

0 · Reply

StockFactz Sep. 23 at 7:07 PM

$ARE LOL wow I didn't expect this to reach 51.50 levels today, I put in my bid at 51.55 let's see if it hits. This stock is too funny man

0 · Reply

ThomasTrainTrader Sep. 23 at 7:00 PM

$ARE macro conditions are shit rn, only 44% of average daily volume btw

0 · Reply

Daniel3303 Sep. 23 at 6:50 PM

$ARE takes this tens of millions of shares to go from 52 to 56 and 2/3 million to go back from 56 to 52. Here it works like this, low volume they manipulate the price back down. Underneath there is someone accumulating

1 · Reply

StockFactz Sep. 23 at 6:38 PM

$ARE Just bought 100 shares for the hell of it, but will probably buy another 500 or so if it reaches $51.50

0 · Reply

StockFactz Sep. 23 at 6:31 PM

$ARE If you look at the price aciton of the last 2 month period something is up. You can tell there is a signfiicant shift in sentiment and people are buying at levels with conviction. I think people are starting to see the earliest proof of the recovery that people on this board have been predicting

0 · Reply

StockFactz Sep. 23 at 6:26 PM

$ARE I was considering buying more today but probbaly will watch the price action for the next month or so before deciding 👍! Seems to be at a pretty stable price recently near what I would consider the bottom end of fair value. Interesting that there seems to be some bigger block sells recently, you would think most institutions would want to hold it until the dividend especially when there has been so much near term strength and positive biotech catalysts

0 · Reply

ThomasTrainTrader Sep. 22 at 8:11 PM

$ARE lmao second day in a row of this bs. One single big selloff right before close, but still only about 7% of the total volume. Clearly the stock wants to go up from here. Shorts are defnitely at least a small factor but I think more likely funds are trying to artificially suppress the price so they can continue to enter. They don’t want this to retest YTD highs. Also there is definitely a non insignificant amount of people trying to sell for profit after the recent come up but I also feel like this number is less than previous times due to a much stronger floor and trend recently. Those people don’t understand the insane potential this has in the next 1-2 years.

0 · Reply

ThomasTrainTrader Sep. 21 at 8:16 PM

$ARE Was a very strong Green Day, but suddenly a 200,000 share dump 5 minutes before close that dropped the price by almost a full 1% just to have a 400,000 share buy right at close. Quite strange

0 · Reply

Market Cap	9.29B
Revenue (ttm)	3.03B
Net Income (ttm)	-1.43B
EPS (ttm)	N/A
PE Ratio	6.80
Forward PE	8.34
Profit Margin	-47.23%
Debt to Equity Ratio	0.67

Volume	1,937,331
Avg Vol	1,919,830
Day's Range	N/A - N/A
Shares Out	174.25M
Stochastic %K	57%
Beta	1.15
Analysts	Hold
Price Target	$53.40